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SUMMARY
AMPA-type glutamate receptors (AMPARs) mediate
fast neurotransmission at excitatory synapses. The
extent and fidelity of postsynaptic depolarization
triggered by AMPAR activation are shaped by
AMPAR auxiliary subunits, including the transmem-
brane AMPAR regulatory proteins (TARPs). TARPs
profoundly influence gating, an effect thought to be
mediated by an interactionwith the AMPAR ion chan-
nel and ligand binding domain (LBD). Here, we show
that the distal N-terminal domain (NTD) contributes
to TARP modulation. Alterations in the NTD-LBD
linker result in TARP-dependent and TARP-selective
changes in AMPAR gating. Using peptide arrays, we
identify a TARP interaction region on the NTD and
define the path of TARP contacts along the LBD sur-
face. Moreover, we map key binding sites on the
TARP itself and show that mutation of these residues
mediates gatingmodulation. Our data reveal a TARP-
dependent allosteric role for the AMPAR NTD and
suggest that TARP binding triggers a drastic reorga-
nization of the AMPAR complex.
INTRODUCTION
AMPA-type glutamate receptors (AMPARs) mediate fast excit-
atory transmission and are crucial for various forms of synaptic
plasticity (Bredt and Nicoll, 2003; Cull-Candy et al., 2006). Their
varied kinetic behavior (Mosbacher et al., 1994), as well as their
calcium permeability and voltage-dependent block by poly-
amines (Cull-Candy et al., 2006; Geiger et al., 1995), varies be-
tween brain regions and appear to be adapted to the specific
function of a given circuit (Jonas, 2000; Trussell, 1998). These
properties depend on the nature and mRNA processing status
of the four pore-forming subunits (GluA1–GluA4) (Traynelis
et al., 2010; Jonas, 2000) and on the type and stoichiometry of
AMPAR auxiliary subunits (Jackson and Nicoll, 2011).
Four families of auxiliary subunits have been identified: trans-
membrane AMPAR regulatory proteins (TARPs) (Tomita et al.,
2005; Turetsky et al., 2005), cornichons (Schwenk et al., 2009),
CKAMP44 (von Engelhardt et al., 2010), and GSG1L (Schwenk
et al., 2012; Shanks et al., 2012). Most of these alter AMPAR
gating and confer effects that can be specific for a given synapse
or cell. TARPs were the first identified bona fide AMPAR auxiliary
proteins, modifying both AMPAR function and trafficking. Based
on their modulatory actions, TARPs have been classified as type
1a (g-2 and g-3), type 1b (g-4 and g-8), and type 2 (g-5 and g-7)
(Kato et al., 2010). TARP-like modulation of AMPARs has also
been seen in invertebrates (Walker et al., 2006; Wang et al.,
2008) and thus appears highly conserved.
The precise nature of the AMPAR/TARP interaction and thus
the mechanism underlying gating modulation are poorly under-
stood. Both the AMPAR transmembrane region and the ligand
binding domain (LBD) have been implicated in TARP interactions
responsible for the modulation of ligand efficacy, pharmacology,
gating, and pore properties (Jackson and Nicoll, 2011). Experi-
ments using domain swapping between subtypes have identi-
fied TARP regions that are involved in regulating AMPARs. These
include the extracellular loop (Ex1), the transmembrane sector,
and the C terminus. Specifically, the TARP C tail appears critical
for receptor trafficking andmediation of kinetic effects, while Ex1
influences both the efficacy of the partial agonist kainate and
AMPAR kinetics (Tomita et al., 2005; Turetsky et al., 2005).
Themost distal AMPAR domain, the N-terminal domain (NTD),
is expected to be beyond the ‘‘reach’’ of the associated TARP.
Apart from a role in subunit assembly, no clear function has
been ascribed to this large and most sequence-diverse domain
(Hansen et al., 2010; Kumar and Mayer, 2013), although deletion
of theNTD slows desensitization kinetics (Bedoukian et al., 2006;
Mo¨ykkynen et al., 2014; Pasternack et al., 2002). In stark
contrast, the NTD of the N-methyl-D-aspartate (NMDA)-type
glutamate receptor (NMDAR) mediates allosteric regulation of
channel open probability (Paoletti, 2011) in a subunit-specific
manner, rendering the NTD an important target for selective
NMDAR drugs (Mony et al., 2009). NTD-mediated allostery in
NMDARs has been shown to involve the 16-residue peptide
linkers that connect the NTD to the LBD (Gielen et al., 2009;
Mony et al., 2011; Yuan et al., 2009).
Here we show that the AMPAR NTD plays a previously unrec-
ognized role in signaling. Shortening of the NTD-LBD linkers
altered desensitization rates and recovery from the desensitized
state and increased the steady-state response. These gating
effects were TARP dependent and TARP specific. Using peptide
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arrays,wemapped theGluA2/TARPcontact regionand identified
TARPbinding sites on theNTD. On the LBD, TARPcontact points
mapped to functionally critical sites, including the ligand binding
cleft, the flip/flop region, and the linkers that connect the LBD to
the ion channel. We also determined the sites on the TARP that
are contacted by the AMPAR and assessed their functional role
using corresponding TARPmutants. Our results provide detailed
insights into the molecular interactions of TARPs with AMPARs
and show that these include the distal NTD. This subunit-specific
TARP regulatory site may permit fine tuning of AMPAR signaling
and provide a target for subunit-selective drugs.
RESULTS
The NTD-LBD Linker Mediates TARP-Dependent
Changes of AMPAR Gating
The iGluR extracellular region comprises two layers (Sobolevsky
et al., 2009; Suzuki et al., 2014), a unique architecture not
observed in other ligand-gated channels. In AMPARs, the func-
tion of the distal NTD layer is unknown. This layer is loosely
connected to the LBD via 17 residue N-glycosylated linkers
(Figure 1A). As these linkers may function as potential ‘‘output’’
regions for NTD-mediated allostery, we created linker mutations
Figure 1. The NTD-LBD Linker Influences TARP-Dependent Changes in AMPAR Gating
(A) Structure of the extracellular region of a GluA2 subunit, showing the NTD (gray), linker (blue), and LBD (yellow) (adapted fromPDB: 3KG2). Sequence alignment
of the rat GluA1-4 NTD linkers, red residues have been mutated in D link with VTxxxLPSG deleted and the two asparagines (N385 and N392 bold, underlined)
mutated to Asp and Gln, respectively (analogous to PDB 3KG2). Model of a complete, stretched NTD linker is shown beneath the alignment.
(B) Representative normalized current responses evoked by 100 ms glutamate application (gray bars). Outside-out patches were pulled from cells transfected
with GluA2iQWT orD link in the absence or presence of g-2 and the decay of the current (60mV) analyzed to determine the time constant of desensitization and
the magnitude of the steady state component. (Inset) Pooled data (mean ± SEM) showing the difference in charge transfer (normalized to the peak) during the
100 ms glutamate application (***p < 0.001, Welch t test).
(C) Pooled data showing the desensitization time constants for GluA2iQWTorD link expressed alone (n = 14 and 10), or with TARPs g-2 (n = 11 and 15), g-3 (n = 14
and 10), g-4 (n = 12 and 17), or g-8 (n = 20 and 15). Currents were fitted with a two-exponential function. The weighted time constant (tw,des) is shown ±SEM. Two-
way ANOVA indicated a significantmain effect of TARP (F4, 111 = 82.28, p = 2.663 10
32), no significantmain effect of linkermutation (F1, 111 = 1.73, p = 0.19) and a
significant interaction between linker and TARP effects (F4, 111 = 10.05, p = 5.61 3 10
7). Asterisks denote significance of difference between WT and D link for
each TARP condition (*p < 0.05, **p < 0.01, ***p < 0.001; Welch t test).
(D) Pooled data showing the ratio of current at the end of the 100 ms glutamate application (steady-state [SS]) to the peak response. The data are plotted and
analyzed as in (C), for GluA2iQWT or D link expressed alone (n = 10 each), or with g-2 (n = 11 and 8), g-3 (n = 14 and 9), g-4 (n = 12 and 17), or g-8 (n = 10 and 15).
There were significant main effects of TARP subtype (F4, 106 = 42.74, p = 2.643 10
21) and linker mutation (F1, 106 = 5.04, p = 0.027) and a significant interaction
between linker and TARP effects (F4, 106 = 8.89, p = 3.16 3 10
6). Asterisks are as in (C).
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and assayed their effect on AMPAR function. Initially, we recre-
ated the modifications that had been used in the GluA2 crystal
structure, GluA2cryst (Sobolevsky et al., 2009), as this provided
direct structural information on the packing between NTD and
LBD. Thus, we deleted six residues plus two N-glycosylation
sites in GluA2(Q607) flip, resulting in the GluA2i linker mutation,
D link (sequence in red; Figure 1A).
While the linker mutation produced no change in channel ki-
netics in the absence of TARP g-2 (Figure 1B, left), in the
presence of g-2, the mutant exhibited a pronounced slowing
of entry into the desensitized state (tw des 11.10 ± 0.82 ms for
GluA2i wild-type [WT] versus 18.56 ± 0.92 ms for D link; n =
11 and 15, respectively) and an 3-fold increase in the
steady-state current (Figures 1B–1D). These changes resulted
in a more than 2-fold increase in normalized charge transfer of
TARPed D link (inset in Figure 1B). Deactivation of the TARPed
receptor was unaltered by the linker mutation (tw, deac 1.07 ±
0.10 ms for GluA2i WT versus 1.09 ± 0.16 ms for D link; n =
15 and 10, respectively).
To determine if this behavior was specific to g-2, wemeasured
desensitization kinetics of D link when associated with other
TARPs. With g-3, the effects of the linker mutation were similar
to those seen with g-2. However, in the presence of g-8, the
linker mutation neither slowed desensitization nor increased
the steady-state component (Figures 1C and 1D). These data
reveal that an alteration in the AMPAR NTD-LBD linker affects
channel gating in a TARP-dependent and TARP-selective
manner.
The NTD-LBD Linker Modulates Recovery from
Desensitization
We next investigated whether the NTD linker has a wider role in
AMPAR function and could affect other aspects of gating that are
regulated by TARPs. TARPs are also known to accelerate recov-
ery from desensitization for GluA1 receptors (Gill et al., 2012;
Priel et al., 2005); our experiments showed that the influence of
TARPs on recovery from desensitization depended both on the
AMPAR subtype and the TARP isoform. Thus, in contrast with
GluA1, recovery from desensitization of GluA2i was unaffected
by the presence of g-2 or g-3 (type 1a TARPs) and was in fact
markedly slowed by g-4 and g-8 (type 1b) (Figure 2 and Fig-
ure S1A available online). A similar pattern was also observed
with GluA3i (Figure S1B), suggesting that accelerated recovery
is specific to GluA1.
The D link mutation resulted in an acceleration of GluA2i re-
covery fromdesensitization. This effect was again TARP subtype
specific and was observed with g-2 and g-8, but not with g-3 or
g-4 (Figure 2). Accelerated recovery together with reduced
desensitization (Figures 1B and 1C) is expected to boost charge
transfer through TARPed D link. Thus, changes in the NTD-LBD
linker have a wider role in AMPAR gating that is TARP
dependent.
Specific Features of theNTD-LBDLinkerMediateGating
Effects
We next pinpointed the minimal regions of the linker able to
mediate gating effects. We focused on the core deletion, LPSG,
Figure 2. The D Link Mutation Accelerates
Recovery from Desensitization in the Pres-
ence of TARPs
(A) Representative traces illustrating recovery from
desensitization (averages of three trials in each
case). A 100 ms pulse of 10 mM L-glutamate was
followed, at increasing intervals, by a 10 ms test
pulse, and the recovery in the amplitude of the test
response was fitted by a monoexponential func-
tion (dashed lines). Currents were normalized to
the first peak, and for clarity, only selected traces
are shown.
(B) Summary of the data presented in (A). Relative
currents at individual time points are shown ±SEM
(error bars masked by the symbols). The solid lines
are monoexponential fits of the average values
(giving time constants of 7.3, 21.8, and 75.6 ms for
GluA2 D link + g-2, GluA2 WT + g-2, and GluA2
WT + g-8, respectively).
(C) Pooled data for the time constant of recovery
from desensitization (trec) for GluA2iQ WT and D
link expressed alone (n = 11 and 8, respectively) or
with TARPs g-2 (n = 17 and 9), g-3 (n = 6 and 5), g-4
(n = 8 each), or g-8 (n = 7 and 8) (shown ± SEM).
Two-way ANOVA showed significant main effects
of TARP subtype (F4, 77 = 62.61, p = 1.913 10
23)
and linker mutation (F1, 77 = 25.58, p = 4.143 10
6)
and a significant interaction between linker and
TARP effects (F4, 77 = 3.14, p = 0.019). Asterisks
denote significance of difference betweenWT and
D link for each TARP condition (*p < 0.05, ***p <
0.001; Welch t test).
See also Figure S1.
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and on two mutations (N385D and N392Q) that abolish
N-glycosylation (Figure 3A) and thus may alter linker flexibility.
Deletion of LPSG slowed GluA2i/g-2 desensitization to a similar
extent to that seen with the complete modification (D link) (Fig-
ure 3B). This phenotype was enhanced when combined with
the glyco double null mutant (LPSG-N385D/N392Q), whereas
mutation of the two glycosylation sites alone had no significant
impact (Figure 3B). A similar trend was observed for the steady-
state response except that N385D and N392Q alone also pro-
duced significant effects (Figure 3C). Hence, the four-residue
linker deletion ‘‘LPSG’’ is necessary and sufficient to confer
the alterations in gating seen with the D link mutant. As linkers
have been suggested to encode structural states (Ma et al.,
2011), our observation raised the question of whether these
effects on gating were merely due to linker shortening or if
they resulted from specific structural effects. To address this,
we introduced an alternative four-residue deletion SGLE
(S388-E391) further downstream (Figure 3A). Unlike DLPSG, the
SGLE deletion did not slow GluA2i/g-2 desensitization and
did not increase the steady state current (Figures 3B and 3C),
indicating that structural changes, rather than linker shortening
alone, are important in mediating TARP-dependent alterations
in GluA2i gating.
To extend this finding, we introduced a deletion into the linker
of GluA3i, at a position analogous to DLPSG in GluA2i (Fig-
ure S2A). This deletion (DQISS) also slowed desensitization in
the presence of g-2, and its effect wasmagnifiedwhen combined
with the glyco null mutation N387D (QISS-N387D; Figure S2B).
However, as observed with GluA2i, a four-residue deletion
introduced further downstream, DSSSE (analogous to GluA2i
DSGLE), had no significant effect (Figure S2B). Hence, NTD-
LBD linkers have a general role in the control of AMPAR gating.
Figure 3. Gating Changes Are Mediated by
Specific Structural Features of the NTD
Linker
(A) Sequence of the GluA2 NTD-LBD linker with
the glycosylation sites and the amino acid qua-
druplets deleted in these experiments highlighted
in red and blue.
(B) Pooled data (mean ± SEM) showing the effects
on desensitization (tw,des) of NTD-LBD linker mu-
tations in GluA2i in presence of g-2. LPSG denotes
a construct with these four amino acids deleted;
LPSG-D combines this with the N385D mutation,
and LPSG-D-Q additionally includes N392Q.
Following one-way ANOVA (F7, 25.7 = 14.69, p =
1.52 3 107), pairwise comparisons showed that
tw,des was slower for LPSG (n = 11), LPSG-D
(n = 6), LPSG-D-Q (n = 16), and D link (n = 7)
compared with WT (n = 11) (**p < 0.01, ***p <
0.001) and was significantly slower for LPSG-D-Q
compared with LPSG (#p < 0.05) (Welch t tests).
There was no significant effect of the glycosylation
mutations N385D (n = 8) or N392Q (n = 10) and
no effect of the alternative deletion mutant,
SGLE (n = 8).
(C) Pooled data for the steady state-to-peak ratio
(SS/peak; presented and analyzed as in B).
Following one-way ANOVA (F7, 26.5 = 17.18, p =
2.34 3 108), pairwise comparisons showed that
the SS/peak ratio was greater for N385D (n = 8),
N392Q (n = 10), LPSG (n = 11), LPSG-D (n = 7),
LPSG-D-Q (n = 16), and D link (n = 7) compared
with WT (n = 9) (**p < 0.01, ***p < 0.001) and
significantly greater for LPSG-D-Q compared to
LPSG (#p < 0.05) (Welch t tests). Again, no effect of
the alternative deletion mutant, SGLE (n = 8).
(D) Pooled data (± SEM) comparing the effects of
the LPSG-D mutation in GluA2 and in a chimeric
construct where the NTD of GluA2 was replaced
by that of GluA3. (Left) tw,des was increased
by LPSG-D in both GluA2 (n = 10 and 6) and
GluA2A3-NTD (n = 14 and 7) (***p < 0.001 and *p <
0.05; Welch t tests). Two-way ANOVA showed
a significant interaction between NTD and linker
(F1, 33 = 11.62, p = 0.0017). Similar results were seen for the SS/peak ratio (right); in this case, the ratio was increased by LPSG-D in GluA2 (***p < 0.001) but not in
GluA2A3-NTD. Again, two-way ANOVA showed a significant interaction between NTD and linker (F1, 33 = 13.10, p = 9.75 3 10
4), confirming that the effect of the
LPSG-D linker mutation was NTD-type specific.
See also Figure S2.
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TARP-Dependent Reorientation of the NTD via the
Linkers
How do NTD linker deletions affect gating of the AMPAR-
TARP complex? While deletion of the NTD is known to alter
desensitization kinetics (Bedoukian et al., 2006; Mo¨ykkynen
et al., 2014; Pasternack et al., 2002), this domain has not been
implicated in TARP modulation to date. In fact, previous work
has questioned a role for the NTD in TARP function (Bedoukian
et al., 2006; Morimoto-Tomita et al., 2009; Tomita et al., 2007).
Similarly, in our hands, the gating properties of AMPARs lacking
the NTD (GluA2i-DNTD), including desensitization kinetics and
kainate efficacy, retained modulation by g-2 (Figures S2C–
S2E). However, these observations do not rule out a functional
role for the NTD, which may trigger a TARP-dependent reorgani-
zation of the receptor (Figure S6B).
The position dependence of the deletions described in Figures
3A–3C suggests that the linker might facilitate a ‘‘preferred’’
orientation of the NTD relative to the LBD, perhaps to optimize
TARP binding and thereby enable the TARP-dependent slowing
of desensitization (Figure 1). As the NTD is highly sequence
diverse, with a sequence identity of 55% between AMPAR
subunits, we replaced the NTD core (lacking the linker) from
GluA2i WT and GluA2i DLPSG-D with that of GluA3 (Figure 3D,
bottom). We reasoned that if a selective positioning of NTD to
LBD created an optimal TARP binding site, then this replacement
would markedly alter this interaction surface. When GluA2i re-
ceptors contained the GluA3 NTD, the effects of the DLPSG-D
mutation on desensitization and steady-state response were
attenuated drastically (Figure 3D). This is consistent with the
view that a specific orientation of the NTD-LBD may allow an
optimal TARP interaction site and hence greater TARP efficacy.
The NTD Stabilizes the AMPAR-TARP g-2 Complex
To establish whether the NTD directly mediates interaction with
TARPs, we first used immunoprecipitation (IP) to test if the NTD
contributes to stabilizing the AMPAR-TARP complex. We trans-
fected either GluA2i WT or GluA2i-DNTD into HEK293T cells
stably expressing TARP g-2, extracted proteins under mild
detergent conditions (Nakagawa et al., 2006) and IPed GluA2i/
g-2 complexes with an anti-g-2 antibody. As shown in Figure 4A,
the fraction of GluA2i-DNTD associating with g-2 was markedly
reduced (lanes 3 + 4) when compared with GluA2i WT (lanes
1 + 2). The ratio of IPed GluA2i WT to GluA2i-DNTD was
3-fold (2.9 ± 0.5; n = 5), when normalized to the input. TARP
expression between conditions was comparable (Figure 4A,
lower panel), and a similar association pattern was evident
in the reverse experiment, where g-2 was IPed with GluA2 (Fig-
ure S3A). Conversely, IP of GluA2i D link with g-2 was similar to
GluA2i WT (Figure S3B) and was not enhanced as one may have
expected from the functional data (Figure 1).
Reduced association with g-2 in absence of the AMPAR NTD
was also observed for GluA1 (data not shown) and for other
GluA2 isoforms, namely uneditedGluA2i-Q607 and for thealterna-
tively spliced GluA2-flop variety (GluA2o-R607). While there was
no obvious difference in TARP association between the WT iso-
forms, we noted an isoform-specific difference between the
DNTD mutants (Figure 4A, lanes 3–8). Specifically, the Q to R
switch at the channel pore reduced coIP by 2-fold (2.2 ± 0.6,
n = 5; lanes 4 versus 6) and the flop D-NTD mutant precipitated
3-fold (2.9 ± 0.3, n = 5) less efficiently than its flip counterpart
(lanes 4 versus 8). These results imply that the NTD contributes
to complex stability and that there are multiple regions on the
AMPAR that mediate association with TARP auxiliary subunits.
Delineating the TARP g-2 Interaction Regions on GluA2
Thus far, our data suggested a reorganization of AMPARs when
associating with TARPs. This prompted us to identify TARP bind-
ing sites on the receptor, which are currently unknown. We uti-
lized peptide arrays, which provide semiquantitative maps of
protein interaction regions (Katz et al., 2011; Shanks et al.,
2014). We first probed an array of overlapping 15 amino acid
peptides representing GluA2with TARP g-2 (Table S1). The array
covered the NTD lower lobe, the NTD-LBD linker, the LBD and
the transmembrane sector (schematic in Figure 4B). TARP g-2
binding was revealed with an anti-g-2 antibody (Supplemental
Experimental Procedures).
As shown in Figures 4C, 4D, and S4, TARP interaction sites
mapped to the LBD, the transmembrane region and indeed
included theNTD. Interestingly, the NTD linker regionwas devoid
of g-2 binding. Even GluA2 peptides mimicking glycosylation
(with GlcNAc-b[1-4]-GlcNAc) at the two N-glycosylation sites,
N385 and N392, were negative (data not shown), suggesting
that the linker is not directly contacted by the TARP but facilitates
a specific orientation of the NTD (which is altered in D link). A
similar pattern was observed with GluA3 where the NTD core
that precedes the linker interacted with g-2, whereas the
linker itself was mostly devoid of signal (Figure S4A). Below we
give a more detailed description of the g-2 contact points
on GluA2.
Regions of the NTD that Interact with g-2
TARP contact regionsmapped to various points on the NTD (Fig-
ures 4C, 4D, and S4). These included the front helices F and H,
which have previously been implicated in NTD dynamics; they
exhibit structural heterogeneity (Sukumaran et al., 2011) and un-
dergo fluctuations when measured at a single-molecule level
(Jensen et al., 2011) and in molecular dynamics simulations
(Dutta et al., 2012). Of note, these helices also form an interface
between NTD dimers (Jin et al., 2009; Sobolevsky et al., 2009),
which may be disrupted by TARP association in the AMPAR
tetramer (orange region in Figure S4B). Interaction sites also
mapped to the side (close to helix H), the back of the NTD (along
helix D), and across the NTD ‘‘floor’’ (Figures 4D, S4B, and S4C).
Regions of Interaction on the GluA2 LBD and the
Transmembrane Sector
The LBD has been suggested as a key TARP modulatory target
(Kato et al., 2010; Tomita et al., 2006, 2007). Our identification of
TARP contact points on strategic regulatory sites on the LBD
offers an explanation for these observations. These included
the upper and lower ‘‘lip’’ of the LBD clamshell (regions A1, A2
in Figures 4C and 4D), the LBD-TMD linker region (region B),
and the alternatively spliced flip/flop cassette (region C; Figures
4D and S4D) (Sommer et al., 1990).
TARP interaction with regions A and B suggests how TARP
binding could modulate AMPAR gating kinetics and agonist
efficacy. Region A stretches across both lobes of the LBD clam-
shell, extending from beta strand 2 in the upper lobe down to
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helix H in the lower lobe (Figures 4D and S4D) and is thus ideally
positioned to affect LBD clamshell motions associated with
gating. Region B encompasses LBD-TMD linkers, which trans-
late LBD motions into channel opening. Strong signals were
apparent in the LBD-TM1 linker but not in LBD-TM4. The TM3
linker, which connects the LBD to the channel gate, is positioned
in the ‘‘interior’’ of GluA2 (Sobolevsky et al., 2009) and may be
less accessible. The transmembrane sector, which exhibits
Figure 4. Mapping the TARP g-2 Contact Region on GluA2
(A) coIP of GluA2 variants with TARP g-2. The blot was probed with polyclonal GluA2 antibody (top panel) and anti g-2 (bottom panel). Both WT and DNTD
protein migrated as monomer (M) and dimer (D), denoted by arrowheads. Note that while inputs were comparable, amounts of IPed GluA2 varied between
conditions.
(B) Schematic of the peptide array layout (right). Each peptide is spotted onto a nitrocellulose membrane (C). Peptide coverage of the rat GluA2 sequence is
outlined in the left panel in color code as indicated. The four GluA2 regions—the NTD lower lobe, the NTD-LBD linkers, the LBD, and the TM segments of the
channel—are highlighted. GluA2 peptide numbers covering each domain are indicated in brackets.
See Table S1 for peptide sequences.
(C) Regions of GluA2 binding to TARP g-2. (Upper panel) Nonspecific signal, resulting from anti-g-2 antibody binding to GluA2 in the absence of the g-2 probe
(‘‘AB control’’). AMPAR domains are highlighted in boxes and match the color scheme in (B). Peptide numbers are indicated on the side. The membrane was
exposed to an X-ray film for 2 min; the arrow denotes nonspecific signals. (Lower panel) The samemembrane was probed with full-length TARP g-2 and detected
with anti-g-2 AB followed by a HRP-labeled secondary AB (2 min exposure). Individual AMPAR secondary structure elements, corresponding to NTD and LBD
helices, are highlighted in stippled boxes on the blot (compared with D). The bottom panel shows a longer exposure for the LBD-A1 region (yellow) and the NTD-
LBD linker (blue).
See Figure S4A for a longer exposure of the blot.
(D) TARP binding sites deduced from the peptide array in (C) are mapped onto the extracellular region of GluA2 (PDB: 3KG2). NTD interaction sites are denoted in
deep red (strong interaction) and light pink (weaker interaction; see graded bar below), with alpha helices contacted by g-2 denoted by (D), (F), and (H). LBD
interaction sites are highlighted in brown (strong interaction) and yellow (weaker interaction). The three core contact regions, A–C, are denoted. Region A spans
the glutamate binding cleft (interaction sites A1 and A2); region B encompasses the LBD-TM linker 1, and region C corresponds to the flip-flop cassette (denoted
with a stippled ellipsoid).
See also Figures S3, S4, and S6 and Table S1.
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prominent swelling in TARP-associated AMPARs (Nakagawa
et al., 2005), also showed signs of interaction. However, this re-
gion also exhibited nonspecific antibody binding, so we cannot
make any specific assignment at present (Figure 4C). Similarly,
strong background signals were observed along LBD helices
F and G.
Region C encompasses the flip/flop cassette (helices J and K),
which also contributed to complex stability in our coIP experi-
ments (Figure 4A). These contacts likely account for the flip/
flop differences in TARP modulation (Kott et al., 2007; Turetsky
et al., 2005) and the altered specificity of AMPAR modulators
in the presence of TARPs (Tomita et al., 2006). As is apparent
in Figure 4D, this region follows a continuous path toward the
interaction patch on the back of the NTD (NTD helix D; Figure 4D,
right), which might tether the LBD to the NTD via the TARP.
Taken together, these results provide a glimpse into the g-2 con-
tact points and reveal the functionally critical regions of the
AMPAR interacting with g-2.
Delineating GluA2 Binding Sites on TARPs g-2 and g-8
Next, we used an array of TARP peptides to identify TARP res-
idues that contact the AMPAR (Table S2). We examined loops
Ex1 and Ex2 (Figure 5A) in both type 1a (g-2) and type 1b (g-8)
TARPs and mapped sites contacted by the NTD and LBD.
Extensive contacts were indeed apparent on both g-2 and
g-8 when we probed the array with the NTD (Figure 5B, lower
panel). Only background signals were obtained when we
omitted the NTD and tested the membrane with the antibody
alone (upper panel). In addition to identifying NTD binding
sites on Ex1, we also detected signals on the smaller Ex2
loop, which is only 30 residues in length and thus not ex-
pected to protrude far above the plane of the plasma mem-
brane. Moreover, in Ex1, the membrane-proximal N and C
termini exhibited regions of NTD interaction. In vivo, these
interactions would require substantial reconfigurations of the
receptor, with the NTD reaching down toward the membrane
(Figure S6B); NTD reconfigurations have been observed in
Figure 5. Mapping TARP g-2 and TARP g-8 Residues Involved in AMPAR Interaction
(A) Alignment of rat type 1a (g-2, g-3) and type 1b (g-4, g-8) TARP extracellular loops, Ex1 and Ex2. Conserved residues are shaded brown, and residues highly
conserved throughout the Cacng family (g-1 to g-8) are boxed in gray. The four cysteines are highlighted in yellow. Curly brackets above the g-2 (green) and below
g-8 alignment (blue) indicate regions in the center of Ex1 interacting with the AMPAR extracellular domains (NTD and LBD).
(B) TARP array encompassing the Ex1 and Ex2 segments of g-2 (green box) and g-8 (blue box) probed with the NTD. (Upper panel) Nonspecific signal, resulting
from direct anti-GluA2 antibody binding to themembrane (AB control). The Ex1 and Ex2 regions for both TARPs are denoted (dashed line). (Lower panel) the same
membrane was exposed to the rat GluA2 NTD followed by probing with anti-GluA2 AB. The membrane exposure time is as indicated.
See Table S2 for peptide sequences.
(C) g-2 and g-8 arrays probed with GluA2 LBD and GluK2 LBD. The negative controls with anti-FLAG AB did not show any signal and thus are not shown.
Membranes were then incubated with FLAG-tagged GluA2 LBD or GluK2 LBD and probed with anti-FLAG AB. (Upper panel) GluA2 LBD interaction with g-2
(same peptides as in Figure 5B, green box). (Central panel) GluA2 LBD interaction with g-8 (same peptides as in B, blue box). (Lower panel) the g-2 membrane
previously probed with GluA2 LBD (top panel) was regenerated and probed with the FLAG-tagged GluK2 LBD, which produced no clear binding. Regeneration of
this membrane resulted in a clear binding pattern when reprobed with the GluA2 LBD that matched the one shown in (C, top).
(D) Schematic representation of TARP structure with the GluA2 NTD and LBD interacting parts of the Ex1 and Ex2 loops highlighted in orange and the highly
conserved GLWR motif indicated.
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low-resolution structures of native AMPARs (Nakagawa et al.,
2005). A prominent interaction region was also present in the
center of Ex1, surrounding the highly conserved GLWRxC67
motif present throughout the vertebrate Cacng family (g-1 to
g-8) (Figures 5A, 5B, and 5D).
The same peptides were also probed with a Flag-tagged
GluA2 LBD. Surprisingly, the LBD interaction sites on the TARPs
g-2 and g-8 largely overlapped with those for the NTD. There
were two noticeable differences: (1) the relative weight of signals
across the Ex1 tip region, surrounding the double cysteine motif,
varied between the LBD andNTD and (2) within Ex1, LBD binding
to the N-terminal end of the loop was greater, whereas interac-
tion with the tip region of the loop was reduced (Figure 5C).
This indicates that the LBD interacts strongly with themembrane
proximal region of Ex1, whereas the NTD binds more intimately
to the Ex1 segment that surrounds the double cysteine motif
(CC67, CC68).
The similarity between the NTD and LBD binding pattern
prompted us to probe the specificity of this interaction further.
As the related kainate receptors do not interact with TARPs
(Chen et al., 2003), we probed the g-2 array with a Flag-tagged
GluK2 LBD (the GluA2 and GluK2 LBDs share only 50%
sequence identity) and did not observe clear binding (Figure 5C,
bottom panel), suggesting that the observed AMPAR/g-2 inter-
action profile is genuine. Together, these results corroborate
an interaction of the NTD with type 1a and type 1b TARPs and
reveal the sites on the TARPs involved in modulating AMPARs.
Interaction Regions in the g-2 Ex1 Loop Are Critical for
TARP Function
To test the functional relevance of the identified binding region
(Figure 5D), we mutated the g-2 Ex1 segment contacting the
AMPAR and examined the effects on GluA2i currents. As shown
in Figure 6A (top), triple and quadruple mutations were intro-
duced into the tip region of Ex1. We tested the ability of TARP
mutants tomodulate channel kinetics, kainate efficacy (Figure 6),
inward rectification, and channel conductance (Figure S5) (Jack-
son et al., 2011; Soto et al., 2007). We found that although all
three g-2 mutants retained some TARP-like functions, various
channel parameters were affected differently and to varying de-
grees. For example, with the KGL74–76 mutation, desensitization
was faster thanwith g-2WT (Figure 6A), whereas kainate efficacy
was unchanged relative to g-2 WT (Figure 6D). On the other
hand, GluA2i coexpressed with KQID78–81 exhibited significantly
lower kainate efficacy than did receptors expressedwith g-2WT,
while desensitization kinetics were comparable. The reduced
kainate efficacy seen with KQID78–81 and WRT64–66 when
compared with g-2 WT suggests that these mutants disrupt
TARP-AMPAR interactions in a way that might affect the degree
of the LBD cleft closure, as this is known to determine the effi-
cacy of partial agonists (Jin et al., 2003).
All g-2 Ex1 mutants increased the weighted-mean channel
conductance of GluA2i to the same extent as g-2 WT (Fig-
ure S5). By contrast, the WRT64–66 mutant produced less relief
of polyamine block than did g-2 WT (Figure S5), where the
effect of the mutation was evident only at positive potentials
(data not shown). These observations suggest that regions of
the TARP distinct from Ex1, such as TM2 may play a role in
modulating AMPAR properties, particularly those related to
ion permeation, which likely result from interactions close to
the channel pore.
Among the Ex1 mutants examined here, the WRT64–66 muta-
tion had the most profound impact on a variety of functional
properties (Figures 6 and S5). WRT64–66 was expressed at lower
levels (50%) than g-2WT; however, thismutant was targeted to
the cell surface and biotinylation experiments revealed that the
proportion of surface-expressed versus internal WRT64–66 was
comparable to the other g-2 mutants (data not shown). In sum-
mary, our results identify functional hotspots in the g-2 Ex1
loop and imply the existence of regions on the TARP that selec-
tively influence different aspects of the AMPAR gating spectrum.
DISCUSSION
In this study, we report a role for the NTD (and the NTD-LBD
linker) in AMPAR modulation by TARPs. We show that the NTD
has the capacity to interact with TARPs and that selective short-
ening of the NTD linker can potentiate the modulatory function of
TARPs in a TARP-selective fashion. Using peptide arrays, we
identify NTD and LBD segments contacting g-2 (Figure S6A),
shedding light on the mechanisms underlying TARP modulation.
In addition, we characterize contact points of the NTD and LBD
on TARPs g-2 and g-8 and identify functional hotspots in the g-2
interaction region. Our results imply that AMPARs are highly
dynamic and may substantially reconfigure when interacting
with auxiliary subunits (Figure S6B). We hypothesize that the
flexible, modular organization of the AMPAR extracellular region
permits selective interaction with other synaptic components,
which may impact allosteric regulation of AMPARs.
The AMPAR Extracellular Region Is Flexible
The extracellular region of AMPA (and kainate) receptors consti-
tutes 80% of the mass of the receptor. The LBD layer is
wedged between the ion channel and the NTD and is connected
to both domains via peptide linkers. This flexible attachment,
together with weak contacts within the LBD layer, is intimately
linked to receptor gating, which requires substantial reconfigura-
tions. In addition to the well-studied intradimer rearrangements
associated with AMPAR desensitization (Armstrong et al.,
2006; Sun et al., 2002), recent data fromGluK2 kainate receptors
reveal complete separation of the four LBDs upon desensitiza-
tion (Schauder et al., 2013). This loose architecture permits large
rearrangements that are required for AMPAR gating on the milli-
second time scale (Plested and Mayer, 2009).
Subunit interactions within the distal NTD layer are substan-
tially tighter as NTD dimers exhibit low nanomolar to low micro-
molar affinities (Herguedas et al., 2013; Rossmann et al., 2011;
Zhao et al., 2012). These dimers associate as tetramers through
a relatively small interface (Clayton et al., 2009; Jin et al., 2009;
Kumar et al., 2009; Sobolevsky et al., 2009), which appears to
be contacted by TARPs (Figure S4B). TARP association could
therefore impact the organization of the distal layer, perhaps in
a state-dependent fashion. Our peptide array data also imply
that interdomain interactions between the NTD and LBD are
altered by TARPs, which may underlie changes in desensitiza-
tion rates observed in response to linker truncation.
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As TARPs are not expected to protrude far beyond the plane of
the membrane (Suzuki et al., 2014), a direct contact between
TARPs and the NTD would require substantial rearrangements
of the receptor. Structural data lend some support to this hypoth-
esis (Nakagawa et al., 2005). Since interactions within a mem-
brane-embedded receptor complex likely differ from those in a
peptide array probed with isolated (and therefore unconstrained)
receptor domains, not all interactions described here may occur
at the same time and may also depend on the functional state of
the receptor. Related to this, TARP contacts may differ between
the two nonequvivalent AMPAR subunits pairs (AC vs. BD;
Sobolevsky et al., 2009).
TARPs Interact with Functionally Critical AMPAR
Regions
Within the LBD, TARP contacts include a number of sites of
functional importance. Interactions across the LBD cleft are
well suited to affect kainate efficacy, the pharmacology of
Figure 6. Effects of Ex1 Mutations in
TARP g-2
(A) Sequence of the g-2 Ex1 region surrounding
the highly conserved GLWRxC67 motif. Boxed
regions in red identify the amino acid triplets and
quadruplet mutated in these experiments.
(B) Pooled data (mean ± SEM) showing the effects
of Ex1 mutations in g-2 on desensitization (tw,des)
of GluA2. Following one-way ANOVA (F4, 23.27 =
28.89, p = 1.01 3 108), pairwise comparisons
showed that g-2 WT (n = 12) and all three g-2
mutants (KGL74–76, KQID78–81, and WRT64–66; n =
12, 8, and 14, respectively) slowed tw,des
compared with GluA2 alone (n = 10) (***p < 0.001)
and that the effects of KGL74–76 and WRT64–66
were less than those of g-2 WT (#p < 0.05, ###p <
0.001) (Welch t tests). To the right are represen-
tative currents evoked by 10 mM L-glutamate
(60 mV) in patches from cells expressing GluA2/
g-2 WT and GluA2/g-2 WRT64–66. Also shown are
the individual tw,des values determined from dou-
ble exponential fits (blue).
(C) Pooled data showing the effects ofmutations in
g-2 on the steady-state/peak ratio (SS/peak).
Presentation, analysis, and n numbers as in B
(F4, 22.91 = 18.26, p = 7.27 3 10
7; **p < 0.01 and
***p < 0.001 compared with GluA2 alone and
###p < 0.001 compared with g-2 WT). To the right
are representative records from GluA2/g-2 WT
and GluA2/g-2 WRT64–66 illustrating the current
remaining at the end of the 100 ms applications of
L-glutamate (10 mM) and the calculated SS/peak
ratio.
(D) Pooled data (±SEM) showing the effects of
mutations in g-2 on GluA2 deactivation (tw,deact;
1 ms, 10 mM L-glutamate, 60 mV). Following
one-way ANOVA (F4, 17.47 = 3.06, p = 0.044),
pairwise comparisons showed that only for g-2
WT (n = 8) was t w,deact slowed compared with
GluA2 alone (n = 8) (*p < 0.05). None of themutants
(KGL74–76, KQID78–81, andWRT64–66; n = 11, 8, and
7, respectively) differed from GluA2 alone or
GluA2/g-2 WT. To the right are representative
currents in patches taken from cells expressing
GluA2/g-2 WT and GluA2/g-2 WRT64–66. Also
shown are the individual tw,deact values deter-
mined from double exponential fits (blue).
(E) Pooled data (± SEM) showing the effects of
mutations in g-2 on the KA/Glu ratio. Following
one-way ANOVA (F4, 9.85 = 44.8, p = 2.72 3 10
6),
pairwise comparisons showed that g-2 WT (n = 5) and all three g-2 mutants (KGL74–76, KQID78–81, and WRT64–66; n = 7, 5, and 8, respectively) increased kainate
efficacy (KA/Glu ratio) comparedwith that seen with GluA2 alone (n = 4) (*p < 0.05, ***p < 0.001) and that KQID78–81 andWRT64–66 had less effect than g-2WT (
#p <
0.05, ###p < 0.001) (Welch t tests). To the right are representative currents evoked by L-glutamate and kainate (both 500 mM, in the presence of 100 mM
cyclothiazide) in patches from cells expressing GluA2/g-2 WT and GluA2/g-2 WRT64–66. Also shown are the KA/Glu ratios for these representative records.
See also Figure S5.
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competitive antagonists, and the open-to-closed equilibrium of
the clamshell (Cho et al., 2007; Milstein et al., 2007). Similarly,
the LBD-TM1 linkers, which are contacted by g-2, are involved
in transmitting gating motions from the LBD to the ion channel
and are thus well suited to shape gating. Curiously, TARPs con-
tact the alternatively spliced flip/flop segment, which, according
to our IP data, impacts the stability of the AMPAR/TARP com-
plex. Our coIP results imply multiple regulatory sites on the re-
ceptor, the Q/R site in the pore, and the flip/flop cassette in the
LBD, which in combination would determine AMPAR affinity for
the TARP. This result highlights the strategic role of flip/flop
splicing in AMPAR regulation (Coleman et al., 2006; Penn
et al., 2012; Sommer et al., 1990). Somewhat unexpectedly,
the GluA2i-DNTD mutant retained modulation by g-2 to compa-
rable levels as GluA2i WT (Figures S2C–S2E). Interestingly,
earlier work showed that while GluA2i lacking the NTD was
potentiated by g-2, the GluA2o-DNTD mutant was not (Bedou-
kian et al., 2006). This may well be explained by the reduced
TARP affinity seen with the flop variety in our coIPs and further
indicates that multiple binding sites on the receptor (Figure S6A)
contribute to elicit optimal TARP modulation.
Surprisingly, on the TARP itself, the GluA2 LBD and NTD con-
tacted comparable regions in the extracellular loops; however,
the relative weights of signal intensities were distinct. This
pattern of interaction is unexpected and prevented us from
selectively mutating residues within LBD versus NTD interaction
regions. Structural data are required to resolve the precise orga-
nization of AMPAR TARP complex. Another curious feature of
our results is the close similarity between g-2 and g-8 in their in-
teractions with AMPAR. These two TARPs are of strikingly
different length and share only48% sequence similarity in their
extracellular regions. As signals across Ex1 centered around the
four cysteines, tertiary structural features of the loop that result
from disulphide bonding (Suzuki et al., 2014) are likely to underlie
this interaction. The functional consequence of theNTD-g8 inter-
action remains to be established.
Functional Implications of TARP-Induced AMPAR
Rearrangements
Acontinuouspath of TARP interaction, extending beyond the flip/
flop region toward the back of the NTD, may permit ‘‘bridging’’
between the NTD and LBD. The resulting compact arrangement
between these two domains may ‘‘incorporate’’ the otherwise
loosely connected NTD layer into an allosteric unit with the LBD
(FigureS6B). TheAMPARrearrangement, triggeredbyTARPs, re-
flects a capacity of the AMPAR for dynamic reorganization that
might permit interactions with other synaptic components, such
as cadherins and pentraxins (Saglietti et al., 2007; Sia et al.,
2007), to impact postsynaptic response properties via the NTD.
The sequence diversity of the NTD, combined with the exis-
tence of multiple TARPs heterogeneously expressed in diverse
neuronal populations,mayprovide further capacity for differential
regulation of AMPAR subtypes. First, the NTD-TARP contact re-
giondescribed in this studymayoffer a target for thedevelopment
of novel AMPAR-subtype selective drugs (Gill and Bredt, 2011).
Second, AMPARs have been suggested to dissociate from
TARPs upon activation by L-glutamate, prior to endocytosis
(Tomita et al., 2004). Thus, AMPAR subunit combinations with
different affinities for TARPs, mediated via the sequence-diverse
NTD, couldexhibit distinct endocytosis rates and lateral diffusion,
influencing thedwell-timeofAMPARsatpostsynaptic sites (Bredt
and Nicoll, 2003; Opazo et al., 2012). Therefore, the extracellular
region of AMPARs might turn out to be a key element for regu-
lating functional and structural plasticity at excitatory synapses.
EXPERIMENTAL PROCEDURES
Additional details are provided in the Supplemental Experimental Procedures.
Protein Production
His-tagged g-2 was produced in insect cells using a P1 baculovirus stock
following a purification protocol provided by T. Nakagawa. High-titer viral
stocks were obtained following the Bac-N-Blue protocol (Invitrogen). Protein
was solubilized with decyl-maltoside and purified by Cobalt-affinity chroma-
tography. The GluA2 NTD was purified from stably transfected GntI
HEK293S cells (Rossmann et al., 2011). A FLAG-tag was introduced at the
GluA2i LBD C terminus (R/Flip; (Armstrong and Gouaux, 2000; Greger et al.,
2006) and the GluK2 LBD (provided by M. Mayer) and cloned into a
pET22b(+) plasmid containing an N-terminal His8 tag and a thrombin cleavage
site. Proteins were produced in Origami B (DE3) cells and purified on a HisTrap
HP column followed by thrombin cleavage and gel filtration.
Peptide Arrays
The interaction betweenGluA2 and TARPs g-2 and g-8 wasmapped with pep-
tide arrays synthesized by SPOT synthesis (PepSpots from JPT Peptide
Tech.). AMPAR and TARP arrays contained 15-mer overlapping peptides
shifted by four residues (Tables S1 and S2). The GluA2 array was probed
with full-length g-2, whereas the TARP g-2 and g-8 arrays were probed with
GluA2 NTD, GluA2 LBD, or GluK2 LBD, following the manufacturer’s protocol.
Prior to exposing the arrays to specific protein probes, the membranes were
incubated with antibodies only to determine nonspecific binding. Membranes
were blocked with 5% BSA and incubated with primary antibodies: anti-FLAG
(monoclonal; Sigma-Aldrich), anti-Stargazin (polyclonal; Millipore), or anti-
GluA2 (polyclonal; Alomone). After incubation with HRP-coupled secondary
antibodies (Pierce), membranes were developed with enhanced chemilumi-
nescence and images were captured electronically with a ChemiDoc MP
Imaging System (Biorad) or on an X-ray film.
Electrophysiology
Voltage-clamp recordings of rat GluA2i (flip, R/G-edited, Q/R-unedited) or
GluA3i (flip, R/G-edited and containing the R463G point mutation for increased
surface expression; Coleman et al., 2010) were performed as described previ-
ously (Rossmann et al., 2011; Soto et al., 2007). Briefly, outside-out patches
were pulled from HEK293(T) cells transfected with rat GluA2i or GluA3i, and
current responses to rapid application of 10 mM L-glutamate via a q tube
were recorded. Where indicated, TARPs were coexpressed, either transiently
cotransfected or using a cell line stably expressing g-2 or g-8. The kinetics of
the receptor desensitization, deactivation, and recovery from desensitization
were analyzed by fitting currents with single- or double-exponential functions.
In addition, steady state-to-peak ratio, relative kainate efficacy, rectification,
and single channel properties (by nonstationary fluctuation analysis) were
assessed.
Statistics
Summary data are presented as the mean ± SEM from n patches. Compari-
sons involving two data sets only were performed using a two-sided Welch
two-sample t test. All analyses involving data from three or more groups
were performed using one- or two-way analysis of variance (Welch heterosce-
dastic F test) followed by pairwise comparisons using two-sided Welch two-
sample t tests (with Holm’s sequential Bonferroni correction for multiple
comparisons). Differences were considered significant at p < 0.05. Statistical
tests were performed using Prism 4.0/6.0 (GraphPad Software) or R (v.3.0.2,
The R Foundation for Statistical Computing, http://www.r-project.org/) and
RStudio (v.0.98.313, RStudio).
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Figure S1. Differential modulation of GluA2 and GluA3 recovery from 
desensitization by Type-1a and -1b TARPs, related to Figure 2. 
A. Graphical summary of recovery from desensitization of GluA2 wt expressed 
with different TARPs. Relative currents at individual time points are shown ± SEM 
(error bars masked by the symbols in most cases). The solid lines are 
monoexponential fits of the averages, giving similar time constants of 18.1 ms, 21.8 
ms and 22.2 ms for GluA2 alone (n = 11), GluA2 with γ-2 (n = 17) and GluA2 with 
γ-3 (n = 6), respectively. Much slower recovery was seen for GluA2 with γ-4 (66.5 
ms; n = 8) and GluA2 with γ-8 (75.6 ms; n = 7). 
B. Pooled data (shown ± SEM) for the time constant of recovery from 
desensitization for GluA3i (R463G) expressed alone or with TARPs γ-2 or γ-8 (n = 9, 
17 and 14, respectively) (*** P < 0.001; two-sided Welch two-sample t-tests with 
Holm’s sequential Bonferroni correction for multiple comparisons).	  
	  	  
 
Figure S2. NTD-LBD linker mutations affect desensitization of GluA3, the effect of 
γ-2 TARP on GluA2 gating is not eliminated in the absence of NTD, related to Figure 
3. 
A. Sequence alignment of the NTD-LBD linkers of GluA2 and GluA3, with the 
deleted/mutated regions highlighted (GluA2 mutants described in Figure 3). 
B.  Pooled data (± SEM) showing the effect of NTD-LBD linker mutations on 
desensitization kinetics of GluA3 in the presence of TARP γ-2. QQIS denotes 
deletion of these four amino acids, QQIS-D combines this with the N387D point 
mutation, while SSSE is an alternative four-amino acid deletion. Values were 
compared using one-way ANOVA. Pairwise comparisons showed that τw,des was 
significantly slower for QQIS (n = 7) and QQIS-D (n = 9) compared to wt (n =31) (** 
P < 0.01, *** P < 0.001) (two-sided Welch two-sample t tests with Holm’s sequential 
	  Bonferroni correction for multiple comparisons). There was no significant effect of 
the glycosylation mutation N394Q (n = 9) or the alternative deletion mutant, SSSE (n 
= 7). 
C.  Pooled data (± SEM) showing the effect of NTD deletion on desensitization 
kinetics of GluA2i. τw,des	  was	   significantly	   increased	  both in the absence (n = 23 
and 16 for GluA2 wt and ΔNTD, respectively) and presence (n = 29 and 25) of TARP 
γ-2 (****	   P	   <	   0.0001;	   two-­‐sided	   Welch	   two-­‐sample	   t	   test).	   Two-­‐way	   ANOVA	  showed	  no	  significant	  interaction	  between	  NTD	  and	  γ-2 presence	  (F1,	  89	  =	  0.69,	  P	  =	  0.4084).	  
D.  Pooled data for the steady state-to-peak ratio, presented and analysed as in C. 
SS/Peak	  was	  significantly	  higher	  for	  the	  ΔNTD	  both in the absence (n = 21 and 16 
for GluA2 wt and ΔNTD, respectively) and presence (n = 28 and 25) of γ-2 (****	  P	  <	  0.0001;	   Welch	   t	   test).	   Here,	   two-­‐way	   ANOVA	   showed	   significant	   interaction	  between	  NTD	  and	  γ-2 presence	  (F1,	  86	  =	  10.41,	  P	  =	  0.0018).	  
E.  Pooled data for the kainate efficacy assay, comparing amplitude of responses 
to kainate and L-glutamate (KA/Glu	  ratio;	  both	  500	  μM,	  in	  the	  presence	  of	  100	  μM	  cyclothiazide), presented and analysed as in C. No difference between GluA2 wt and 
ΔNTD either in absence (P = 0.2064; n = 6 for both) or presence (P = 0.6105; n = 8 
for both) of γ-2. Two-­‐way	   ANOVA	   showed	   no	   significant	   interaction	   between	  NTD	  and	  γ-2 presence	  (F1,	  24	  =	  9.733	  ×	  10−4,	  P	  =	  0.9754). 
	   
 
Figure S3. Immunoprecipitation (IP) of TARP γ-2 with GluA2i mutants, related to 
Figure 4. 
A. Representative IP of γ-2 with GluA2i-wt (left) and GluA2i-ΔNTD (right). The 
blot was probed with polyclonal anti γ-2 (top panel) and anti-Flag antibody to detect 
GluA2i. Substantially less γ-2 precipitated with the ΔNTD mutant. Both wt and 
ΔNTD GluA2i migrated as monomer (M) and dimer (D), denoted by arrowheads. 
Note that inputs were comparable, while amounts of IPed TARP γ-2 varied between 
conditions. 
B. Representative IP of GluA2i-wt (left) and GluA2i-Δlink (right) with γ-2. 
There was no visible difference between GluA2i-wt and the Δlink mutant with regard 
to TARP γ-2 association. The lower panel show that comparable amounts of γ-2 were 
present in the two reactions. 
	   
	  
Figure S4.  Mapping the TARP γ-2 contact region on GluA2, related to Figure 4. 
A.  Regions of GluA2 and GluA3 AMPARs binding to TARP γ-2. Array 
membrane containing GluA2 and -A3 peptides was probed with anti-γ-2 antibody 
only (AB control, top panel), or incubated with purified γ-2 protein before AB-
probing (lower panel) and exposed for 20 minutes. Note the absence of γ-2 signal 
across the GluA2 linker region (blue box). The NTD-binding region is boxed in red, 
the LBD region in grey and the TM segments in green. Peptide numbers are indicated 
on the sides. Lower panel shows the binding of TARP γ-2 to the GluA3 region 
	  flanking the NTD-LBD linker. Binding is observed for the GluA3 NTD and LBD but 
not for the linker peptides. Non-specific signals are indicated by the tilted white arrow. 
B. TARP γ-2 interaction sites on the GluA2 NTD. Contact sites are shown in 
deep-red (strong interaction) or light pink (weaker interaction). The orange footprint 
outlines the tetrameric interface that is formed between two NTD dimers in crystal 
structures. The bottom panel shows the GluA2 NTD dimer superposed on the full-
length structure (PDB: 3KG2), with the tetrameric interface (between the NTD 
dimers) coloured in orange. The stippled line denotes the NTD dimer interface. Upper 
lobe (UL), lower lobe (LL). 
C. TARP γ-2 interactions with the NTD “floor” (a potential NTD-LBD interface). 
The relative strength of binding is indicated by the same colour gradient as in panel B. 
The positions of helices H and F are indicated. The stippled line denotes the dimer 
interface. 
D. TARP γ-2 interactions with the LBD. Structural elements involved in the 
TARP-interaction are shown in brown (strong interaction) and yellow (weaker 
interaction) in front view (left) and side view (right). Contacts spanning the ligand-
binding cleft region are indicated by the red line (‘TARP bridge’) and involve β-2 in 
the LBD upper lobe and helix H in the lower lobe. LBD helices J and K are the target 
of alternative splicing (flip-flop). 
	   
 
 
Figure S5. Effects of Ex1 mutations in TARP γ-2 on GluA2 channel conductance 
and rectification, related to Figure 6. 
A. Pooled data (mean ± SEM) showing the effects of Ex1 mutations in γ-2 on 
weighted mean single-channel conductance from NSFA (10 mM L-glutamate, 100 ms, 
–60 mV). Values were compared using one-way ANOVA (Welch heteroscedastic F 
test: F4, 21.02 = 12.26, P = 2.67 × 10−5). Pairwise comparisons showed that γ-2 wt (n = 
12) and all three γ-2 mutants (KGL74-76, KQID78-81 and WRT64-66; n = 11, 7 and 13, 
respectively) increased channel conductance compared to that of GluA2 alone (n = 8) 
(** P < 0.01, *** P < 0.001) (two-sided Welch two-sample t-tests with Holm’s 
sequential Bonferroni correction for multiple comparisons). For each of the mutants, 
the conductance was not statistically different from that seen with γ-2 wt.  Shown to 
the right are representative individual current-variance plots for GluA2/ γ-2 wt and 
	  GluA2/ γ-2 WRT64-66. The single channel current (i) is derived from the fitted curve 
(solid line); the dashed line indicates the background variance. 
B. Pooled data showing the effects of mutations in γ-2 on the rectification index 
(RI) of GluA2. Presentation and analysis as in A (F4, 18.16 = 79.31, P = 3.02 × 10−11; 
*** P < 0.001 compared to GluA2 alone and ### P < 0.001 compared to γ-2 wt). 
Shown to the right are representative normalized I-V plots from patches expressing 
GluA2/ γ-2 wt and GluA2/ γ-2 WRT64-66. Fitted curves are 8th order polynomials. Note 
that WRT64-66 produced less change in RI than did γ-2 wt. This change in RI appeared 
to reflect changes in spermine permeation, as the effects of WRT64-66 were evident in 
the outward limb of the I-V but not apparent at negative voltages, where the 
conductance-voltage plots were essentially indistinguishable (data not shown). 
 
	   
 
Figure S6.  TARP contacts with the NTD may require AMPAR reorganization, 
related to Figure 4. 
A. TARP γ-2 contact region mapped onto the GluA2 tetramer (PDB: 3KG2). 
Binding sites on the NTD, LBD and LBD-TMD linkers are indicated in red. The 
position where L-glutamate binds is indicated with stars. The potential movement 
NTDs need to undergo to contact the TARPs is denoted with grey arrows.  
B. Model outlining the reorganization in the AMPAR extracellular region that 
may accompany TARP interaction. Left panel: Without TARP, the NTD and LBD are 
loosely connected. Any potential allosteric signal emanating from the NTD is not 
transmitted to the LBD (and the receptor), i.e. the NTD is functionally isolated 
(yellow circles). Right panel: The TARP ‘bridges’ NTD and LBD. This requires 
substantial receptor reconfiguration mediated by the NTD-LBD linkers.  As a result 
the NTD and LBD are functionally connected (yellow ellipsoid). 	  
	  	  
 GluA2 NTD  GluA2 LBD 81 GVARVRKSKGKYAYL 
1 DLKGALLSLIEYYQW 40 VTTILESPYVMMKKN 82 VRKSKGKYAYLLEST 
2 ALLSLIEYYQWDKFA 41 LESPYVMMKKNHEML 83 KYAYLLESTMNEYIE 
3 LIEYYQWDKFAYLYD 42 MMKKNHEMLEGNERY 84 LLESTMNEYIEQRKP 
4 YQWDKFAYLYDSDRG 43 NHEMLEGNERYEGYC 85 NEYIEQRKPCDTMKV 
5 KFAYLYDSDRGLSTL 44 LEGNERYEGYCVDLA 86 EQRKPCDTMKVGGNL 
6 LYDSDRGLSTLQAVL 45 ERYEGYCVDLAAEIA 87 CDTMKVGGNLDSKGY 
7 RGLSTLQAVLDSAAE 46 GYCVDLAAEIAKHCG 88 KVGGNLDSKGYGIAT 
8 AVLDSAAEKKWQVTA 47 DLAAEIAKHCGFKYK 89 NLDSKGYGIATPKGS 
9 AEKKWQVTAINVGNI 48 EIAKHCGFKYKLTIV 90 KGYGIATPKGSSLGN 
10 WQVTAINVGNINNDK 49 CGFKYKLTIVGDGKY 91 IATPKGSSLGNAVNL 
11 AINVGNINNDKKDET 50 YKLTIVGDGKYGARD 92 KGSSLGNAVNLAVLK 
12 GNINNDKKDETYRSL 51 IVGDGKYGARDADTK 93 LGNAVNLAVLKLNEQ 
13 KDETYRSLFQDLELK 52 GKYGARDADTKIWNG 94 VNLAVLKLNEQGLLD 
14 YRSLFQDLELKKERR 53 ARDADTKIWNGMVGE 95 VLKLNEQGLLDKLKN 
15 DLELKKERRVILDCE 54 DTKIWNGMVGELVYG 96 NEQGLLDKLKNKWWY 
16 KKERRVILDCERDKV 55 WNGMVGELVYGKADI 97 LLDKLKNKWWYDKGE 
17 RVILDCERDKVNDIV 56 VGELVYGKADIAIAP 98 LKNKWWYDKGECGSG 
18 DCERDKVNDIVDQVI 57 VYGKADIAIAPLTIT 99 WYDKGECGSGGGDSK 
19 VNDIVDQVITIGKHV 58 ADIAIAPLTITLVRE 100 GECGSGGGDSKEKTS 
20 DQVITIGKHVKGYHY 59 IAPLTITLVREEVID 101 GGGDSKEKTSALSLS 
21 IGKHVKGYHYIIANL 60 TITLVREEVIDFSKP 102 GGDSKEKTSALSLSN 
22 VKGYHYIIANLGFTD 61 REEVIDFSKPFMSLG  GluA3 Linker 
23 HYIIANLGFTDGDLL 62 IDFSKPFMSLGISIM 103 MKVSGSRKAGYWNEY 
24 ANLGFTDGDLLKIQF 63 KPFMSLGISIMIKKP 104 GSRKAGYWNEYERFV 
25 FTDGDLLKIQFGGAN 64 LGISIMIKKPQKSKP 105 AGYWNEYERFVPFSD 
26 LLKIQFGGANVSGFQ 65 GISIMIKKPQKSKPG 106 NEYERFVPFSDQQIS 
27 LKIQFGGANVSGFQI 66 VERMVSPIESAEDLS 107 VPFSDQQISNDSSSS 
28 TINIMELKTNGPRKI 67 MVSPIESAEDLSKQT 108 DQQISNDSSSSENRT 
29 INIMELKTNGPRKIG 68 IESAEDLSKQTEIAY 109 NDSSSSENRTIVVTT 
30 IMELKTNGPRKIGYW 69 EDLSKQTEIAYGTLD 110 SSENRTIVVTTILES 
31 KTNGPRKIGYWSEVD 70 KQTEIAYGTLDSGST 111 RTIVVTTILESPYVM 
32 RKIGYWSEVDKMVVT 71 YGTLDSGSTKEFFRR 112 VTTILESPYVMYKKN 
  72 SGSTKEFFRRSKIAV  GluA2 TMs  
 GluA2 Linker 73 KEFFRRSKIAVFDKM 113 YEIWMCIVFAYIGVS 
33 YWSEVDKMVVTLTEL 74 RRSKIAVFDKMWTYM 114 VFAYIGVSVVLFLVS 
34 VDKMVVTLTELPSGN 75 IAVFDKMWTYMRSAE 115 FGIFNSLWFSLGAFM 
35 VVTLTELPSGNDTSG 76 DKMWTYMRSAEPSVF 116 SLWFSLGAFMQQGCD 
36 TELPSGNDTSGLENK 77 YMRSAEPSVFVRTTA 117 VWWFFTLIIISSYTA 
37 NDTSGLENKTVVVTT 78 AEPSVFVRTTAEGVA 118 IIISSYTANLAAFLT 
38 GLENKTVVVTTILES 79 VFVRTTAEGVARVRK 119 VAGVFYILVGGLGLA 
39 KTVVVTTILESPYVM 80 TTAEGVARVRKSKGK 120 VGGLGLAMLVALIEF 
 
	   
 
Table S1. Sequences of peptides immobilized in the GluA2 array, related to Figure 4. 
 
Peptides include residues 107-238, 348-510, 520-541, 568-587 and 601-811 of 
mature GluA2o. Peptide numbering and colour code match Figure 4 and S4. Array 
also includes residues 360-413 of the GluA3 NTD-LBD linker (shown in Figure S4A). 	  
	  	  
  γ-2  γ-8  
  Ex1  Ex1  
 1 DYWLYSRGVCKTKSV 22 (1) STDYWLYTRALICNT  
 2 YSRGVCKTKSVSENE 23 (2) WLYTRALICNTTNLT  
 3 VCKTKSVSENETSKK 24 (3) RALICNTTNLTAGDD  
 4 KSVSENETSKKNEEV 25 (4) CNTTNLTAGDDGPPH  
 5 ENETSKKNEEVMTHS 26 (5) NLTAGDDGPPHRGGS  
 6 SKKNEEVMTHSGLWR 27 (6) GDDGPPHRGGSGSSE  
 7 EEVMTHSGLWRTCCL 28 (7) PPHRGGSGSSEKKDP  
 8 THSGLWRTCCLEGNF 29 (8) GGSGSSEKKDPGGLT  
 9 LWRTCCLEGNFKGLC 30 (9) SSEKKDPGGLTHSGL  
 10 CCLEGNFKGLCKQID 31 (10) KDPGGLTHSGLWRIC  
 11 GNFKGLCKQIDHFPE 32 (11) GLTHSGLWRICCLEG  
 12 GLCKQIDHFPEDADY 33 (12) SGLWRICCLEGLKRG  
 13 QIDHFPEDADYEADT 34 (13) RICCLEGLKRGVCVK  
 14 FPEDADYEADTAEYF 35 (14) LEGLKRGVCVKINHF  
 15 ADYEADTAEYFLRAV 36 (15) KRGVCVKINHFPEDT  
 16 YEADTAEYFLRAVRA 37 (16) CVKINHFPEDTDYDH  
   38 (17) NHFPEDTDYDHDSAE  
   39 (18) EDTDYDHDSAEYLLR  
   40 (19) YDHDSAEYLLRVVRA  
   41 (20) DHDSAEYLLRVVRAS  
  Ex2  Ex2  
 17 VYISANAGDPSKSDS 42 (21) VYISANAGEPGPKRD  
 18 ANAGDPSKSDSKKNS 43 (22) ANAGEPGPKRDEEKK  
 19 DPSKSDSKKNSYSYG 44 (23) EPGPKRDEEKKNHYS  
 20 SDSKKNSYSYGWSFY 45 (24) KRDEEKKNHYSYGWS  
 21 DSKKNSYSYGWSFYF 46 (25) DEEKKNHYSYGWSFY  	  
Table S2. Sequences of peptides immobilized in the TARP arrays, related to Figure 5.	  
Ex1 and Ex2 denote the two extracellular loops of TARPs. Peptide numbering 
matches Figure 5, which contains both TARPs in the same membrane.  Numbers in 
parentheses correspond to peptides in 5C (central panel), which only contains γ-8. 
Colour code as in Figure 5.	  	  
	  	  
Supplemental Experimental Procedures	  	  
Protein preparation 
His-tagged γ-2 was produced in insect cells using a P1 baculovirus stock and a 
purification protocol provided by T. Nakagawa. The high-titer viral stocks were 
obtained following the Bac-N-BlueTM protocol from Invitrogen. Briefly, 1 x 106 SF9 
cells were plated into a 25 cm2 flask containing 5 ml of complete TNM-FH medium 
(Sigma Aldrich) and infected with 20 µl of the P1 viral stock. The flask was incubated 
at 27 °C until all the cells were lysed; 4 ml of this supernatant (the P2 viral stock) 
were used to infect 500 ml of SF9 cells at a density of 1 x 106 SF9 cells/ml. The 
culture was incubated for 1 week and the high-titer P3 viral stock was recovered by 
centrifugation and kept at 4 °C until infection. For protein production, 500-2000 ml of 
SF9 cells grown in SF900TM II serum-free medium  (Gibco®) were infected with P3 
high-titer viral stock and incubated for 48-72 hours. Cells were collected by 
centrifugation and re-suspended in 20 mM HEPES, pH 7.35, 320 mM sucrose, 5 mM 
EDTA, 5 mM EGTA, protease inhibitors (Roche) using a Dounce homogenizer. Cells 
were sonicated and membranes were washed in consecutive steps of re-suspension 
and ultracentrifugation using 1 M KI, 4 M urea and 20 mM imidazole in 20 mM 
HEPES, pH 7.35. Membrane protein solubilization was performed in 0.6 % decyl-
maltoside (DM). After ultracentrifugation, the supernatant containing the His-tagged 
γ-2 was incubated with chelating sepharose beads (GE Healthcare) charged with Co2+ 
and the protein was eluted with 250 mM imidazole, 0.3 % DM, 20 mM HEPES, pH 
7.35, 150 mM NaCl. Protein was concentrated, flash-frozen and conserved at -20 °C. 
	  γ-2 concentration was estimated spectrophotometrically using the theoretical 
extinction coefficient in water, 39.2 mM-1 cm-1. 
 
The GluA2 NTD was produced and purified from stably transfected GntI- HEK293S 
cells as described previously (Rossmann et al., 2011). The purification consisted of 
cross-flow concentration and dialysis against 50 mM Tris pH 8, 150 mM NaCl; 
affinity purification with a HisTrap HP column (GE Healthcare) and gel filtration 
using a HiLoadTM SuperdexTM 200 column (GE Healthcare). The pure glycosylated 
GluA2 NTD was concentrated in 20 mM HEPES, 150 mM NaCl, pH 7.4 and kept at 4 
°C. 
 
The GluA2i LBD  (S1S2J R/flip construct) was sub-cloned with different tags in 
order to allow its detection in the peptide arrays.  GluA2i LBD was first sub-cloned 
into the pGEX4T-2 vector (GE Healthcare), which contains an N-terminal GST-tag 
followed by a thrombin cleavage site. The plasmid was transformed into Escherichia 
coli Origami B (DE3) and grown at 37 °C to A600=0.9-1. Cultures were cooled to 18 
°C and expression was induced by the addition of 0.4 mM IPTG. Cultures were 
grown at 18 °C for 20 hours. Cells were sonicated and the lysate was incubated with 
Glutathione Sepharose 4b beads (GE Healthcare). The protein was eluted with 10 mM 
reduced-Glutathione and further purified using a Superdex 200 10/300 column (GE 
Healthcare). Protein was flash-frozen and kept at -20 °C until used.  
 
A Flag-tag (DYKDDDDK) was also introduced by PCR at the C-terminus of GluA2i 
LBD and the gene was subcloned into a modified pET22b(+) plasmid containing an 
N-terminal His8 affinity tag and a thrombin cleavage site. The plasmid was 
	  transformed into E. coli Origami B (DE3) cells and cultures were grown at 37 °C until 
A600 reached 0.6–0.9. Cells were cooled to 18 °C and over-expression was induced 
with 0.4 mM IPTG for 20 hours. After cell lysis, protein was purified by affinity 
chromatography using a HisTrap HP column (GE Healthcare) followed by thrombin 
cleavage and gel filtration chromatography (HiLoadTM SuperdexTM 200 column, GE 
Healthcare).  
 
The same procedure was used to add a Flag-tag to the GluK2 LBD S1S2 construct 
(provided by Mark L. Mayer). The resulting protein includes a 19 peptide (MH8 
SSGLVPRGSAM) containing a thrombin cleavage site, the residues S398–K513 and 
P636–E775 of GluK2 connected by a GT linker and the Flag-tag at the C-terminus 
(DYKDDDDK). The protein production and purification protocol was the same as 
described for the GluA2i LBD Flag. Both Flag-tagged proteins were concentrated in 
20 mM HEPES, 150 mM NaCl, pH 7.4, 1 mM L-glutamate and conserved at -20 °C. 
 
Immunoprecipitations 
HEK293 cells were transfected with vectors expression GluA2-IRES-EGFP and 
TARP γ-2 (IRES-RFP) at a ratio of 4:1, alternatively GluA2 was transfected into 
HEK cells stably expressing γ-2. After 2 days of expression, cells were washed with 
cold PBS, scraped into PBS containing protease inhibitors and centrifuged for 10 
mins at 10K rpm for in an Eppendorf 5424R. Pellets were extracted in 1% CHAPS 
buffer containing in (mM): HEPES (20; pH 7.4), NaCl (150), EDTA (2), 1% CHAPS 
and protease inhibitors for 45 mins at 4˚C. Extracts were centrifuged for 30 min at 
4˚C in an Eppendorf 5424R centrifuge at full speed. Supernatants were IPed with 5 μg 
of anti- γ-2 AB (Millipore) for 2 hrs at 4˚C and precipitated with 10 μl of equilibrated 
	  (in CHAPS buffer) protein A beads (Santa Cruz). Lysates were run on 4-12% Bolt 
gels (Invitrogen) and gels analyzed by Western blotting. 
 
Peptide arrays 
To analyze the interaction between AMPAR and TARPs we obtained peptide arrays 
synthesized by SPOT synthesis on Whatman 50 cellulose membranes  (PepSpotsTM; 
JPT Peptide Technologies GmbH).  AMPAR and TARP arrays contained 15-mer 
overlapping peptides shifted by 4 residues. The AMPAR array contained 128 peptides 
covering the lower lobe of GluA2 NTD, the NTD-LBD linkers with and without 
glycosylated residues (GluA2 and -A3 subunits), the GluA2 LBD and the four trans-
membrane helices (Figure 4B, Table S1). The TARP array contained 46 peptides 
covering the two extracellular loops (Ex1 and Ex2) of γ-2 and γ-8 (Figure 5, Table 
S2). 
 
Membranes were probed according to manufacturer instructions.  As these 
membranes cannot be regenerated reliably, control experiments with the antibodies 
(ABs) were performed prior to incubation with the test proteins. Controls were 
essential and extensive to select the most adequate blocking agents, antibodies and 
protein tags, as some ABs showed false positives or high background in the cellulose 
membranes. Anti-His and anti-GST ABs showed signals in the control experiments 
whereas Flag M2 AB (Sigma), anti-AMPAR 2 (extracellular) AB (Alomone) or anti-
Stargazin AB (Millipore) controls showed few false positives (Figures 4C and 5B).  
 
For the protein binding assay, membranes were rinsed with methanol for 5 minutes, 
washed 3 times with TBS and incubated with blocking solution (5 % BSA in TBS) 
	  for 2 hours at RT or overnight at 4 °C. After blocking, arrays were incubated with the 
test proteins overnight at 4 °C.  The AMPAR array was incubated with ∼2.8 µM γ-2 
in blocking solution with 0.15 % DM. TARP arrays were incubated with ∼1.6 µM 
GluA2 NTD, ∼1.6 µM GluA2i LBD-Flag or ∼1.6 µM GluK2 LBD-Flag in blocking 
solution. Membranes were washed three times in TBS and incubated for 1-2 hours at 
RT with the following ABs: anti-AMPAR 2 (extracellular) AB (Alomone) diluted 
1:250 in blocking solution; anti-Stargazin AB (Millipore) diluted 1:1000 in blocking 
solution; and monoclonal anti-Flag M2 antibody (Sigma) diluted 1:1000 in blocking 
solution. After 3 washes with TBS membranes were incubated for 1 hour at RT with 
HRP-conjugated anti-rabbit AB (Pierce) (1:1500 in blocking buffer) or 2 hours at RT 
with HRP-conjugated anti-mouse AB (Pierce) (1:1000 in blocking buffer). 
Membranes were washed 3 times, developed using chemiluminescence (Amersham 
ECL solution) and images were captured electronically with a ChemiDocTM MP 
Imaging System  (Biorad) or on X-ray film. Films were scanned and edited with 
Photoshop CS4 using auto-tone editing followed by a change to gray-scale mode.  
 
Heterologous expression 
HEK293 or HEK293T cells (ATCC), cultured at 37°C and 5% CO2 in DMEM 
(Gibco) supplemented with 10% fetal bovine serum and penicillin/streptomycin, were 
transiently transfected with plasmid DNA using Effectene (Qiagen) or Lipofectamine 
2000 (Invitrogen). After 24-32 hours (Effectene) or 8-14 hours (Lipofectamine 2000), 
the cells were split onto poly-L-lysine-coated glass coverslips and 
electrophysiological recordings were performed 12-48 hours later. When co-
transfected with TARPs, cells were grown in the presence of 30-50 μM 2,3-dioxo-6-
	  nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX; Tocris-ABCam) 
to avoid AMPAR-mediated toxicity. 
 
Electrophysiology  
Cells were visualized with an inverted microscope (Diaphot 200; Nikon) or fixed 
stage upright microscope (Axioskop FS1; Zeiss) and perfused with an ‘external’ 
solution containing (in mM): NaCl (145), KCl (3), CaCl2 (2), MgCl2 (1), glucose (10) 
and HEPES (10), adjusted to pH 7.4 with NaOH. Electrodes were fabricated from 
borosilicate glass (1.5mm o.d., 0.86mm i.d., Science Products GmbH or Harvard 
Apparatus) pulled with a PC-10 vertical puller (Narishige). When filled with an 
‘internal’ solution, containing (mM): CsF (120), CsCl (10), EGTA (10), ATP-sodium 
salt (2), and HEPES (10), adjusted to pH 7.3 with CsOH, they had a final resistance of 
2-5 MΩ. Macroscopic currents were recorded at room temperature (RT; 22-25 ˚C) 
from outside-out patches excised from GFP-positive cells and voltage-clamped at –60 
mV. Currents were recorded with Axopatch 1D, 200A or 2D amplifiers, low-pass 
filtered at 10 kHz and digitized at 50 kHz using a Digidata 1440A interface with 
pClamp 9 or 10 software (Molecular Devices).  
For the experiments described in Figures 6 and S5 there were minor modifications of 
some experimental details; these reflected the established protocols of the two 
participating labs and, where compared directly, did not affect the outcome. For the 
experiments on TARP Ex1 mutants (Figures 6 and S5) the external solution 
contained  (in mM) NaCl (145), KCl (2.5), CaCl2 (1), MgCl2 (1), glucose (10) and 
HEPES (10), adjusted to pH 7.3 with NaOH. The internal solution contained (in mM) 
CsCl (145), EGTA (1), ATP-magnesium salt (4), NaCl (2.5) and HEPES (10), 
adjusted to pH 7.3 with CsOH. Electrodes were coated with Sylgard (Dow Corning 
	  184) and had a final resistance of 6-14 MΩ. Aside from experiments in which 
KA/Glu ratios were measured, spermine tetrahydrochloride (100 μM; Tocris 
Bioscience or Sigma Aldrich) was added to the internal solution.  
 
Agonist application to excised patches 
Rapid agonist application was achieved by switching between a continuously flowing 
control solution and an agonist-containing solution, applied via a theta-barrel 
application tool made from borosilicate glass (2mm o.d.; Hilgenberg GmbH) pulled to 
a tip diameter of ~200 μm and mounted on a piezoelectric translator (Burleigh PZS 
200 or LSS-3000/PZ-150M; EXFO Life Sciences & Industrial Division). At the end 
of each experiment, the adequacy of the solution exchange was assessed by 
destroying the patch and measuring liquid-junction current at the open pipette (typical 
10% - 90% solution exchange time of ~200 μs).  
 
Kinetics of AMPAR-mediated responses 
Desensitization of AMPARs was examined in response to 100 ms applications of 10 
mM L-glutamate. The averaged currents were fitted using a double-exponential 
function to calculate the weighted time constant of desensitization (τw,des) according 
to: 
 
 
 
where Af and τf are the amplitude and time constant of the fast component of 
desensitization and As and τs are the amplitude and time constant of the slow 
	  component of desensitization.  The weighted time constant of deactivation (τw,deact) 
was determined in a similar manner, by fitting the current decay following 1 ms 
applications of 10 mM L-glutamate. In some cases the desensitization or deactivation 
time course was best described by a single exponential. The steady state-to-peak ratio 
(SS/peak) was determined as the current at the end of the 100 ms pulse divided by the 
peak current.  
 
Recovery from desensitization was assessed by a paired-pulse protocol where a 100 
ms desensitizing pulse was followed by a 10 ms pulse in increasing intervals. The 
relative response to the second pulse (usually the average of three consecutive runs) 
was then plotted against time elapsed from the first pulse and the time course fitted 
with a single-exponential function to obtain the time constant of recovery (τrec). 
 
Relative kainate efficacy  
The effects of TARPs on the efficacy of the partial agonist kainate (KA) were 
determined by measuring changes in KA/Glu ratios. Each patch was exposed to L-
glutamate (500 μM; 15 applications of 100 ms duration, –60 mV), then KA (500 μM), 
and then L-glutamate again. Both control and agonist solutions contained 100 μM 
cyclothiazide to block AMPAR desensitization. The amplitude of the steady state 
current response to KA was compared to average amplitude of the steady state current 
responses to L-glutamate obtained before and after KA application.    
 
Non-stationary fluctuation analysis (NSFA) 
To deduce channel properties from macroscopic responses, L-glutamate (10 mM) was 
applied to outside-out patches (100 ms duration, 1 Hz, Vhold –60mV) and the ensemble 
	  variance of all successive pairs of current responses were calculated (Conti et al., 
1980). The single channel current (i) and the total number of channels in the patch (N) 
were determined by plotting this ensemble variance against mean current (I) and 
fitting with a parabolic function (Sigworth, 1980): 
 
where σ2B is the background variance. The weighted-mean single-channel 
conductance was determined from the single-channel current and the holding 
potential. No correction for liquid-junction potential was used.  
 
Current-voltage (I-V) plots and the quantification of rectification 
I-V plots were generated from the peak current response to 1 ms applications of 10 
mM glutamate. The voltage was stepped from –100 mV to +60 mV in 10 mV 
increments. Mean current amplitudes at each voltage were normalized to the peak 
current at –100 mV and plotted against membrane potential. The relationships were 
fitted with 8th or 9th order polynomials. The rectification index (RI) was determined 
from the I-V relationship of each patch as the ratio of slope conductance at positive 
(+40 mV to +60 mV) and negative voltages (–40 mV to –60 mV). Thus, for a 
completely linear I-V relationship RI would equal 1. 
 
Analysis and statistics 
Recordings were analyzed using IGOR Pro (Wavemetrics Inc.) with NeuroMatic (J. 
Rothman, UCL; http://www.neuromatic.thinkrandom.com). Summary data are 
presented in the text as the mean ± SEM from n patches and in the figures as bar plots 
of the group mean, with error bars denoting SEM. Comparisons involving two data 
	  sets only were performed using a two-sided Welch two-sample t test. All analyses 
involving data from three or more groups were performed using one- or two-way 
analysis of variance (Welch heteroscedastic F test) followed by pairwise comparisons 
using two-sided Welch two-sample t tests (with Holm’s sequential Bonferroni 
correction for multiple comparisons). Differences were considered significant at P < 
0.05. Statistical tests were performed using Prism 4.0/6.0 (GraphPad Software Inc.) or 
R (version 3.0.2, The R Foundation for Statistical Computing, http://www.r-
project.org/) and RStudio (version 0.98.313, RStudio, Inc.). 
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